phase readout
saveNCT07368478: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Biocity Biopharmaceutics Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Malignancies
view source ↗
comments(0)
5-min edit window · permanent after that